The Importance of Promoting and Clarifying the Community Use of the New Therapeutic Weapons against COVID-19

Authors

DOI:

https://doi.org/10.20344/amp.18987

Keywords:

Antiviral Agents, COVID-19/drug therapy, SARS-CoV-2

Abstract

N/a.

Downloads

Download data is not yet available.

References

Barreiro I, Matos M, de Oliveira M, Guerra D, Fonseca T, Abreu M, et al. Intrahospital protocol for the management of COVID-19 disease in adults. Acta Med Port. 2022;35:593-603.

Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao Weihang, Wisemandle W, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19. N Engl J Med. 2022;386:1397-408.

Direção-Geral da Saúde. Norma nº 005-2022 de 28/05/2022. COVID-19 – Terapêutica farmacológica para a COVID-19. Lisboa: DGS; 2022.

World Health Organization. Therapeutics and COVID-19: living guideline, 14 July 2022. Geneva: WHO; 2022.

Published

2022-09-26

How to Cite

1.
Sarmento de Beires T, Sequeira Eiras A. The Importance of Promoting and Clarifying the Community Use of the New Therapeutic Weapons against COVID-19. Acta Med Port [Internet]. 2022 Sep. 26 [cited 2022 Dec. 7];35(11):848-. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/18987

Issue

Section

Letters to the Editor